MSN and cancer: MSN was significantly higher expressed in primary tumors of peritoneal metastasis patients (Fig. 2d) and CMS4 primary CRCs (Fig. 2e), indicating that MSN expression is not increased in peritoneal lesions but already present in the primary cancers from which the peritoneal metastases derive.